Impax Asset Management Group plc Sells 150,385 Shares of Waters Corporation $WAT

Impax Asset Management Group plc cut its position in Waters Corporation (NYSE:WAT) by 35.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 274,368 shares of the medical instruments supplier’s stock after selling 150,385 shares during the period. Impax Asset Management Group plc owned 0.46% of Waters worth $95,765,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of WAT. Swedbank AB raised its position in shares of Waters by 25.8% during the second quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock worth $14,145,000 after acquiring an additional 8,305 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Waters by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier’s stock worth $195,599,000 after purchasing an additional 28,018 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its holdings in Waters by 12.6% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,021 shares of the medical instruments supplier’s stock worth $2,800,000 after purchasing an additional 896 shares during the last quarter. Jacobs Levy Equity Management Inc. acquired a new position in Waters during the 1st quarter valued at about $1,244,000. Finally, Mn Services Vermogensbeheer B.V. boosted its stake in shares of Waters by 7.0% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 22,933 shares of the medical instruments supplier’s stock valued at $8,005,000 after purchasing an additional 1,500 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

WAT opened at $387.26 on Thursday. The stock has a market cap of $23.06 billion, a P/E ratio of 34.92, a P/E/G ratio of 3.19 and a beta of 1.11. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The company has a fifty day simple moving average of $328.80 and a 200 day simple moving average of $327.04.

Waters (NYSE:WAT) last posted its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $608.55 million for the quarter. On average, research analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on WAT shares. JPMorgan Chase & Co. boosted their price target on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. TD Cowen increased their price target on Waters from $345.00 to $390.00 and gave the company a “hold” rating in a research note on Wednesday, November 5th. Jefferies Financial Group set a $385.00 price target on Waters and gave the stock a “buy” rating in a research report on Monday, August 4th. Rothschild Redb upgraded Waters to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Robert W. Baird cut their target price on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, Waters currently has a consensus rating of “Moderate Buy” and a consensus price target of $381.57.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.